Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001171843-22-004514

Options or other derivatives

  • PRESIDENT & CEO acquired 560,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
D'Alvise Janelle PRESIDENT & CEO 2022-06-22 Grant or award · Stock Options (Right to Buy) +560,000 560,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…